Success Metrics

Clinical Success Rate
75.0%

Based on 9 completed trials

Completion Rate
75%(9/12)
Active Trials
2(10%)
Results Posted
33%(3 trials)
Terminated
3(14%)

Phase Distribution

Ph not_applicable
16
76%
Ph phase_1
3
14%
Ph phase_2
1
5%

Phase Distribution

3

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
3(15.0%)
Phase 2Efficacy & side effects
1(5.0%)
N/ANon-phased studies
16(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

9 of 15 finished

Non-Completion Rate

40.0%

6 ended early

Currently Active

2

trials recruiting

Total Trials

21

all time

Status Distribution
Active(4)
Completed(9)
Terminated(6)
Other(2)

Detailed Status

Completed9
Withdrawn3
Terminated3
unknown2
Recruiting2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
21
Active
2
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (15.0%)
Phase 21 (5.0%)
N/A16 (80.0%)

Trials by Status

withdrawn314%
completed943%
unknown210%
recruiting210%
not_yet_recruiting210%
terminated314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT05036200Not Applicable

Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma

Completed
NCT04429607Phase 2

Treatment of Sebaceous Hyperplasia With PDL and Nd:YAG Versus Erbium:YAG: A Randomized Controlled Trial

Not Yet Recruiting
NCT01488240Not Applicable

The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars

Recruiting
NCT06591208Not Applicable

Study the Effect of Pulsed Dye Laser Versus Carboxytherapy in the Treatment of Striae Rubra

Not Yet Recruiting
NCT01873131Not Applicable

A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

Recruiting
NCT01775722Not Applicable

Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment

Completed
NCT00667472Phase 1

Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Withdrawn
NCT00969397Phase 1

Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks

Withdrawn
NCT03465280

Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)

Unknown
NCT04795310Not Applicable

Clinical Observation of Pulsed Dye Laser and Intense Pulsed Light in Treating Facial Telangiectasia

Completed
NCT04461366Not Applicable

Monopolar Radiofrequency Versus Pulsed Dye Laser for Treatment of Acne Scars

Completed
NCT03986346Not Applicable

The Vascularity Changes of Scars With Laser Therapy

Completed
NCT00945373Phase 1

Combination Therapy for the Treatment of Rosacea

Completed
NCT00735254Not Applicable

Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars

Terminated
NCT02090517Not Applicable

Laser Therapy Versus Electrosurgery For Nasal Telangiectasias

Withdrawn
NCT02214706Not Applicable

Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus

Terminated
NCT01654406Not Applicable

Fractional CO2 Laser in the Treatment for Cesarian Scar

Terminated
NCT00142441Not Applicable

Effect of Pulse Width on Scar Treatment Using a 595-nm Pulsed Dye Laser

Completed
NCT00710203Not Applicable

Dermatosis Papulosa Nigra

Completed
NCT01052246Not Applicable

Pulsed Dye Laser Treatment of Acne Vulgaris

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
21